Cancer immunotherapy: GDF-15’s role in Anti-PD-1 resistance
Drug Target Review
AUGUST 24, 2023
We will explore how GDF-15 impacts the tumour microenvironment and hinders the infiltration of T cells into the tumour, as well as the implications of neutralising GDF-15 to reverse its inhibitory effects and sensitise tumours to anti-PD-1 treatment. T-cell infiltration is a prerequisite for responses to checkpoint inhibitors.
Let's personalize your content